• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB INC. ENVISTA INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB INC. ENVISTA INTRAOCULAR LENS Back to Search Results
Model Number EE
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Endophthalmitis (1835); Hypopyon (1913); Visual Impairment (2138); Toxic Anterior Segment Syndrome (TASS) (4469)
Date of Event 02/14/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device remains implanted.Investigation of this event is in progress.Recall of device is underway.
 
Event or Problem Description
It was reported that 1 day after implantation of an intraocular lens (iol) into the left eye, the patient presented with decreased visual acuity, increased iop (pre-op 14 mmhg and post op 22 mmhg), hypopyon and possible endophthalmitis.Based on the findings the surgeon concluded the cause as toxic anterior segment syndrome (tass).Cultures were taken and the results were negative.The patient was treated with intraocular injections of ceftazidine and vancomycin, sub tenons kenalog, durezol and ofloxacin.In the surgeon¿s opinion, the most likely cause of the event was related to the implanted iol.Patient outcome was reported to be good.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVISTA INTRAOCULAR LENS
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
BAUSCH + LOMB INC.
1400 north goodman street
rochester NY 14609
Manufacturer (Section G)
BAUSCH + LOMB, INC
21 north park place blvd.
clearwater FL 33759
Manufacturer Contact
shayan habibi
21 north park place blvd.
clearwater, FL 33759
7277246600
MDR Report Key21896675
Report Number0001313525-2025-00091
Device Sequence Number11650918
Product Code HQL
UDI-Device Identifier10757770607898
UDI-Public(01)10757770607898(17)271031(11)241127(10)3Q32454
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P910056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial
Report Date (Section B) 03/27/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberEE
Device Catalogue NumberEEU2100
Device Lot Number3Q32454
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/16/2025
Initial Report FDA Received Date04/23/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/27/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
RES96594
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PROVISC
Outcome Attributed to Adverse Event Required Intervention;
Patient Age66 YR
Patient SexFemale
-
-